A detailed history of Keel Point, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Keel Point, LLC holds 14,672 shares of PFE stock, worth $378,977. This represents 0.04% of its overall portfolio holdings.

Number of Shares
14,672
Previous 14,169 3.55%
Holding current value
$378,977
Previous $396,000 7.07%
% of portfolio
0.04%
Previous 0.04%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $13,933 - $15,789
503 Added 3.55%
14,672 $424,000
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $357,908 - $419,402
14,169 New
14,169 $396,000
Q4 2023

Jan 30, 2024

BUY
$26.13 - $33.94 $186,881 - $242,738
7,152 New
7,152 $205,000
Q2 2023

Jul 12, 2023

BUY
$36.12 - $41.79 $52,482 - $60,720
1,453 Added 19.09%
9,066 $332,000
Q1 2023

Apr 03, 2023

SELL
$39.39 - $51.28 $85,279 - $111,021
-2,165 Reduced 22.14%
7,613 $310,000
Q4 2022

Jan 17, 2023

SELL
$41.75 - $54.5 $46,259 - $60,386
-1,108 Reduced 10.18%
9,778 $0
Q3 2022

Oct 05, 2022

BUY
$43.76 - $53.42 $7,964 - $9,722
182 Added 1.7%
10,886 $476,000
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $43,552 - $51,639
936 Added 9.58%
10,704 $535,000
Q1 2022

Apr 27, 2022

BUY
$45.75 - $56.69 $104,081 - $128,969
2,275 Added 30.36%
9,768 $506,000
Q4 2021

Jan 31, 2022

BUY
$41.32 - $61.25 $21,982 - $32,585
532 Added 7.64%
7,493 $442,000
Q3 2021

Nov 04, 2021

BUY
$39.25 - $50.42 $208,260 - $267,528
5,306 Added 320.6%
6,961 $299,000
Q2 2021

Aug 06, 2021

SELL
$35.91 - $40.68 $156,028 - $176,754
-4,345 Reduced 72.42%
1,655 $1.82 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $200,940 - $226,620
6,000 New
6,000 $217,000
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $232,646 - $282,234
-7,724 Closed
0 $0
Q1 2020

May 01, 2020

BUY
$27.03 - $38.62 $2,648 - $3,784
98 Added 1.29%
7,724 $252,000
Q4 2019

Feb 07, 2020

BUY
$32.92 - $37.36 $26,434 - $30,000
803 Added 11.77%
7,626 $299,000
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $162 - $210
5 Added 0.07%
6,823 $245,000
Q2 2019

Aug 08, 2019

SELL
$36.98 - $41.52 $3,661 - $4,110
-99 Reduced 1.43%
6,818 $295,000
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $101,475 - $111,487
-2,706 Reduced 28.12%
6,917 $294,000
Q4 2018

Feb 08, 2019

SELL
$38.47 - $43.86 $50,818 - $57,939
-1,321 Reduced 12.07%
9,623 $420,000
Q3 2018

Nov 07, 2018

SELL
$34.47 - $41.81 $18,820 - $22,828
-546 Reduced 4.75%
10,944 $482,000
Q2 2018

Aug 13, 2018

BUY
$32.98 - $35.16 $3,429 - $3,656
104 Added 0.91%
11,490 $417,000
Q1 2018

May 07, 2018

SELL
$31.91 - $37.02 $6,445 - $7,478
-202 Reduced 1.74%
11,386 $404,000
Q4 2017

Feb 08, 2018

SELL
$33.26 - $35.29 $174,315 - $184,954
-5,241 Reduced 31.14%
11,588 $420,000
Q3 2017

Nov 09, 2017

SELL
$31.0 - $34.15 $60,636 - $66,797
-1,956 Reduced 10.41%
16,829 $601,000
Q2 2017

Aug 15, 2017

BUY
N/A
18,785
18,785 $631,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Keel Point, LLC Portfolio

Follow Keel Point, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.